Christopher Robinson: Understanding Lateral Hysterotomy Hematoma in Cesarean Delivery
Christopher Robinson, Executive Chair at the Foundation for the Society for Maternal-Fetal Medicine and Associate Professor of Maternal-Fetal Medicine at the University of South Carolina, shared a post on LinkedIn about a recent article by José Miguel Palacios-Jaraquemada et al., published in American Journal of Obstetrics and Gynecology:
”AJOG Expert Review in Cesarean:
Essential anatomical knowledge for performing routine and complex cesarean delivery – Lateral hysterotomy hematoma
Anterior view of the uterus. Hemorrhage between the 2 layers of the broad ligament extends to the retroperitoneal space. Clinically, this presents with hemodynamic deterioration, and initial imaging studies (ultrasonography) may yield false-negative results due to the bleeding’s deep posterior location.”
Title: Essential anatomical knowledge for performing routine and complex cesarean delivery
Authors: José Miguel Palacios-Jaraquemada, Álbaro José Nieto-Calvache, Nicolás Andrés Basanta, Rozi Aditya Aryananda, Marcelo Alejandro Martínez
Read the Full Article on American Journal of Obstetrics and Gynecology
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 30, 2026, 14:32Jecko Thachil: Elevated Ferritin in the Absence of Iron Overload
-
Mar 30, 2026, 14:26Michael Baria: Key Findings on the Impact of Exercise on PRP
-
Mar 30, 2026, 14:25Training the Next Generation in Hemostasis through IAHAD Masterclass – IAHAD
-
Mar 30, 2026, 14:24Heghine Khachatryan: Reversible Causes of Dementia from a Hematologic Perspective
-
Mar 30, 2026, 14:22Thierry Burnouf: Platelet-Derived Products as Acellular Biotherapies for Neurological Disorders
-
Mar 30, 2026, 14:21Mohamed Sikkander Abdul Razak: Addressing Underdiagnosis of Bleeding Disorders in Women With Heavy Menstrual Bleeding
-
Mar 30, 2026, 14:20William Aird: Thinking Before Searching in Clinical Decision Making
-
Mar 30, 2026, 14:11Chokri Ben Lamine: Strategic Decision Making in Hematology under Competing Risks
-
Mar 30, 2026, 14:10Erwin Loh: Primary Prevention of Cardiovascular Events With Evolocumab in High-Risk Patients With Diabetes